Skip to main content

Trust AI

Category: AI in Healthcare

Trust AI is an AI-powered co-pilot for dentists, designed to enhance clinical excellence and patient trust by providing real-time diagnostics, personalized treatment plans, and comprehensive clinical decision support. Trust AI was founded in 2025. The company is led by Bernard Casse. Based in San Francisco, USA. Team size: 11-50. Total funding raised: $6 million. Latest round: Seed Round. Key investors include Wehrle Implant Immersion Center, Goetze Dental, Rockwood Programs.

Founded
2025
Headquarters
San Francisco, USA
Team size
11-50
Total funding
$6 million

Value proposition

Trust AI aims to solve critical issues in dentistry, including the professional isolation of dentists, patient distrust in treatment recommendations, and inefficiencies in treatment planning. It provides a data-driven 'second opinion,' helping dentists make faster, more informed decisions and enabling them to communicate treatment plans to patients with greater transparency and confidence.

Products and solutions

Isaac: The AI Co-pilot for Dentists, which includes features for real-time diagnostics from dental X-rays, personalized treatment planning, and clinical decision support.

Unique value

Trust AI differentiates itself by positioning its product not just as a diagnostic tool, but as a comprehensive 'AI co-pilot' or 'ChatGPT for dentists.' This approach focuses on augmenting the entire clinical workflow, from analysis to patient communication. The emphasis is on building trust—both for the dentist in their own decision-making and from the patient in the proposed treatment.

Target customer

The primary target customers are dentists and dental practices. Given the nature of the product, it is also highly relevant for Dental Support Organizations (DSOs) looking to standardize and improve care quality across their networks.

Industries served

Dental Industry, Healthcare AI

Technology advantage

The company's core advantage lies in its founding team, which combines deep expertise in AI and robotics (CEO Bernard Casse) with extensive clinical and practice management experience from its dentist co-founders (Dr. Divian Patel, Dr. Shervin Molayem). This blend ensures the product is technologically advanced while being grounded in the real-world needs of dental practitioners. Its rapid, word-of-mouth adoption suggests a strong product-market fit and a powerful network effect, where the AI model continuously improves as more clinical data is integrated.

How they differentiate

Trust AI's key differentiator is its AI model, Isaac, which is trained from its inception on millions of pages of dental literature and real specialist cases, unlike competitors who may use more generic AI models as add-ons to existing healthcare platforms. This specialized training allows for more accurate and context-aware clinical insights.

Main competitors

VideaAI, Pearl, Overjet

Key partnerships

The company's seed funding round was led by a consortium of over 40 prominent dental industry leaders and clinicians, including the esteemed Dr. Gordon Christensen. This provides not only capital but also a deep strategic network and validation from within the dental community.

Notable customers

The platform has attracted over 3,000 dentists within weeks of its launch.

Major milestones

Raised the largest seed round ever for a dental technology startup., Rapid user acquisition, reaching over 3,000 dentists in a short period.

Growth metrics

Trust AI is reportedly adding around 500 new users per week.

Market positioning

Trust AI is positioning itself as a transformative 'ChatGPT for dentists,' aiming to become an indispensable AI co-pilot for dental practices. It is experiencing rapid, word-of-mouth adoption, making it one of the fastest-growing dental startups. The company's focus is on enhancing clinical excellence and patient trust through its specialized AI.

Geographic focus

United States

Patents and IP

As of the latest available information, there are no publicly disclosed patents held by Trust AI. This is common for a startup at this early stage.

About Bernard Casse

Bernard Casse is a deep-tech entrepreneur and physicist with a background in building and leading companies at the intersection of AI, hardware, and life sciences. He was previously the co-founder and CEO of RIOS, an AI and robotics company for factory automation. He also has experience from PARC, a Xerox company, where he led a team in advanced manufacturing and metamaterials.

Official website: